Skip to content

V-Trak 7210-0152-A2Recalls & reported problems

Microvention, Inc. · HydroSoft Advanced · Class 2 · Implant

All models of V-Trak (75)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00816777023025), received between Nov 7, 2018 and Nov 7, 2018 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Neuropathy1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 7, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT AN UNEVENTFUL BALLOON ASSISTED COILING PROCEDURE FOR A RUPTURED RIGHT POSTERIOR COMMUNICATING ARTERY ANEURYSM WAS PERFORMED ON A PATIENT THAT PRESENTED WITH SUDDEN HEADACHE, REDUCED CONSCIOUS LEVEL, AND SUBARACHNOID HEMORRHAGE. POST PROCEDURE, THE PATIENT WOKE UP WITH IPSILATERAL 3RD NERVE PALSY. THE CONDITION DID NOT IMPROVE WITH A SHORT COURSE OF STEROIDS, AND THE PATIENT UNDERWENT NEUROSURGICAL NERVE DECOMPRESSION TWO (2) DAYS LATER, WHICH WAS BELIEVED TO BE A RESULT OF AN IMMEDIATE MASS EFFECT OF THE COILED ANEURYSM ON THE 3RD NERVE. THE PATIENT IS ENROLLED IN A POST-MARKET CLINICAL TRIAL.

    Patient problems: Neuropathy

    MAUDE report 8049352 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page